Matthew P. Young
CIK 1601583 · EVP & CFO · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
JAZZ price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
5TH FL, WATERLOO EXCHANGE, WATERLOO RD
DUBLIN L2 4, L2 0
Holdings By Company
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| PRAH | Direct | 0 | — | 2021-07-01 |
| By Trust | 0 | — | 2017-11-17 | |
| Total | 0 |
Recent Filings · Page 3 of 5
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-25 | PRA Health Sciences, Inc. (PRAH) Delisted | Grant (A) | +1,307 | $0 | EDGAR |
| 2018-06-19 | JAZZ | Sell (S) | −700 | -$123.9K | EDGAR |
| 2018-06-15 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2018-06-05 | JAZZ | Mixed | — | -$556.6K | EDGAR |
| 2018-05-16 | JAZZ | Mixed | −2,262 | -$373.6K | EDGAR |
| 2018-04-18 | JAZZ | Sell (S) | −700 | -$109.2K | EDGAR |
| 2018-03-19 | JAZZ | Sell (S) | −700 | -$105.9K | EDGAR |
| 2018-03-07 | JAZZ | Mixed | −2,500 | -$357.3K | EDGAR |
| 2018-03-05 | JAZZ | Grant (A) | +9,400 | $0 | EDGAR |
| 2018-02-28 | JAZZ | Mixed | −5,994 | -$879.7K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).